中国肺癌杂志2016，Vol.19Issue(8)：530-532,3.DOI:10.3779/j.issn.1009-3419.2016.08.08
非小细胞肺癌脑转移的靶向和免疫治疗
Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer with Brain Metastasis
宋琪 1焦顺昌 1李方1
作者信息
- 1. 100853 北京，解放军总医院肿瘤内一科
- 折叠
摘要
Abstract
Brain metastasis, a common complication of non-small cell lung cancer (NSCLC) with an incidence rate of 30%-50%, signiifcantly affects the patients’ quality of life. hTe prognosis of patients of NSCLC with brain metastasis is ex-tremely poor, the average median survival is only 1 m-2 m without treatment. hTe targeted therapy based on lung cancer driven gene is a new treatment. Besides, the immunotherapy which can enhance the effect of anti-cancer by simulating the immune system is a new approach. The combination of targeted therapy and immunotherapy can greatly benefit patients in clinical work.关键词
肺肿瘤/脑转移/靶向治疗/免疫治疗Key words
Lung neoplasms/Brain metastasis/Immunotherapy/Targeted therapy引用本文复制引用
宋琪,焦顺昌,李方..非小细胞肺癌脑转移的靶向和免疫治疗[J].中国肺癌杂志,2016,19(8):530-532,3.
